Related Read: 14 Peptides Are About to Become Legal Again What This Means for Your Health What the science says about peptide stacking as a category 1) Combination trials are the exception, not the rule For many popular peptides, we have: mechanistic arguments small studies (sometimes in narrow contexts) preclinical work We rarely have: well-powered, long-term human trials on the combination hard outcomes (function, cardiometabolic endpoints, durability, safety) 2) Stacking amplifies the two biggest risks in this space Quality risk (variable purity, contamination, labeling issues) Physiology risk (more pathways affected, more unintended effects) 3) The GH/IGF-1 axis is where stacking gets most clinically delicate CJC-1295 has human data showing it raises GH/IGF-1
PMID: 59 Pekovic-VaughanVGibbsJYoshitaneHYangNPathiranageDGuoBet al
In another small study in healthy men with cardiovascular risk factors, those with abnormal reactive hyperemia index (RHI) which measures peripheral endothelial function and stiffness, experienced a significant reduction in arterial stiffness after taking sublingual glutathione
Compared to mammalian 3-MST, Leishmania 3-MST contains an additional 70 amino acids in the C-terminal domain
Rho Nutrition was founded by Ryan Bishop and George Padilla to raise the standard of modern supplementation
Importantly, information regarding the indications, dosing, frequency, and duration of treatment remains unknown